Lv12
70 积分 2025-09-06 加入
Nivolumab+AVD in Advanced-Stage Classic Hodgkin’s Lymphoma
1小时前
待确认
Phase III study of brentuximab vedotin plus doxorubicin, vinblastine, and dacarbazine (A+AVD) versus doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD) as front-line treatment for advanced classical Hodgkin lymphoma (HL)
16小时前
已关闭
Abstract Book for the 27th Congress of the European Hematology Association
23小时前
求助中
T-Cell Lymphoma
9天前
已关闭
Classic Hodgkin Lymphoma in Adolescents and Young Adults
1个月前
已完结
Pembrolizumab versus brentuximab vedotin in relapsed or refractory classical Hodgkin lymphoma (KEYNOTE-204): an interim analysis of a multicentre, randomised, open-label, phase 3 study
1个月前
已完结
Treatment outcomes for patients with newly diagnosed or relapsed/refractory TP53-mutated mantle cell lymphoma: a systematic review and meta-analysis
1个月前
已完结
Hodgkin lymphoma
1个月前
已完结
Safety and efficacy of BCMA CAR-T <i>vs.</i> bispecific antibodies in patients with relapsed multiple myeloma: a systematic review and meta-analysis
1个月前
已完结
How I Treat Older Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma
1个月前
已完结
皖公网安备34019202002308
